CytoMed Therapeutics Limited (GDTC)

Last Closing Price: 1.18 (2026-06-03)

Consolidated Net Income/Loss (Quarterly)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

CytoMed Therapeutics Limited (GDTC) Consolidated Net Income/Loss data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
Consolidated Net Income/Loss
--
--
--
--
--
--
--
--
Balance Sheet Financials
$2.85M
$4.59M
$5.08M
$6.21M
$0.55M
$0.33M
$0.33M
$0.88M
$5.33M
$5.23M
$5.33M
--
Cash Flow Statement Financials
$-2.88M
$0.72M
$0.16M
$3.65M
$1.63M
$-2.02M
--
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--